![Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/885ca759-bb56-41a4-9388-8b65b362eb92/mfig002.jpg)
Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library
![Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure–Activity Relationships Insights and Evolution Prospects | Journal of Medicinal Chemistry Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure–Activity Relationships Insights and Evolution Prospects | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00047/asset/images/large/jm2c00047_0007.jpeg)
Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure–Activity Relationships Insights and Evolution Prospects | Journal of Medicinal Chemistry
![Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/085feb85-ea89-495d-8c9f-e199ae88ecc1/mcontent.gif)
Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
![Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00172/asset/images/large/jm1c00172_0002.jpeg)
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry
![Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure–Activity Relationships Insights and Evolution Prospects | Journal of Medicinal Chemistry Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure–Activity Relationships Insights and Evolution Prospects | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00047/asset/images/large/jm2c00047_0026.jpeg)
Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure–Activity Relationships Insights and Evolution Prospects | Journal of Medicinal Chemistry
![Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00172/asset/images/large/jm1c00172_0014.jpeg)
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
![Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library Structure‐Based and in silico Design of Hsp90 Inhibitors - Sgobba - 2009 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/027a39d7-09d2-40a3-94fb-4f9b2ef76c79/mfig001.jpg)